Michael D. West
2017 - Serina Therapeutics
In 2017, Michael D. West earned a total compensation of $1.1M as Chief Executive Officer at Serina Therapeutics.
Compensation breakdown
| Option Awards | $865,720 |
|---|---|
| Salary | $272,126 |
| Total | $1,137,846 |
West received $865.7K in option awards, accounting for 76% of the total pay in 2017.
West also received $272.1K in salary.
Rankings
In 2017, Michael D. West's compensation ranked 8,368th out of 14,666 executives tracked by ExecPay. In other words, West earned more than 42.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,368 out of 14,666 | 43rd |
Division Manufacturing | 3,174 out of 5,772 | 45th |
Major group Chemicals And Allied Products | 1,051 out of 2,075 | 49th |
Industry group Drugs | 828 out of 1,731 | 52nd |
Industry Pharmaceutical Preparations | 647 out of 1,333 | 52nd |
Source: SEC filing on November 29, 2019.
West's colleagues
We found two more compensation records of executives who worked with Michael D. West at Serina Therapeutics in 2017.
News
Serina Therapeutics CEO Michael West's 2020 pay falls 46% to $561K
November 24, 2021
Serina Therapeutics CEO Michael West's 2019 pay falls 24% to $1M
November 24, 2020
Serina Therapeutics CEO Michael West's 2018 pay rises 2% to $1.7M
November 29, 2019
BioTime CEO Brian Culley's 2018 pay jumps 75% to $2.8M
June 14, 2019